Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

The guanylate cyclase C agonist linaclotide ameliorates the gut-cardio-renal axis in an adenine-induced mouse model of chronic kidney disease.

Nanto-Hara F, Kanemitsu Y, Fukuda S, Kikuchi K, Asaji K, Saigusa D, Iwasaki T, Ho HJ, Mishima E, Suzuki T, Suzuki C, Tsukimi T, Matsuhashi T, Oikawa Y, Akiyama Y, Kure S, Owada Y, Tomioka Y, Soga T, Ito S, Abe T.

Nephrol Dial Transplant. 2019 Aug 14. pii: gfz126. doi: 10.1093/ndt/gfz126. [Epub ahead of print]

PMID:
31411705
2.

Gut microbiome-derived phenyl sulfate contributes to albuminuria in diabetic kidney disease.

Kikuchi K, Saigusa D, Kanemitsu Y, Matsumoto Y, Thanai P, Suzuki N, Mise K, Yamaguchi H, Nakamura T, Asaji K, Mukawa C, Tsukamoto H, Sato T, Oikawa Y, Iwasaki T, Oe Y, Tsukimi T, Fukuda NN, Ho HJ, Nanto-Hara F, Ogura J, Saito R, Nagao S, Ohsaki Y, Shimada S, Suzuki T, Toyohara T, Mishima E, Shima H, Akiyama Y, Akiyama Y, Ichijo M, Matsuhashi T, Matsuo A, Ogata Y, Yang CC, Suzuki C, Breeggemann MC, Heymann J, Shimizu M, Ogawa S, Takahashi N, Suzuki T, Owada Y, Kure S, Mano N, Soga T, Wada T, Kopp JB, Fukuda S, Hozawa A, Yamamoto M, Ito S, Wada J, Tomioka Y, Abe T.

Nat Commun. 2019 Apr 23;10(1):1835. doi: 10.1038/s41467-019-09735-4.

3.

Renin-angiotensin system inhibitors in hypertensive adults with non-diabetic CKD with or without proteinuria: a systematic review and meta-analysis of randomized trials.

Mishima E, Haruna Y, Arima H.

Hypertens Res. 2019 Apr;42(4):469-482. doi: 10.1038/s41440-018-0116-3. Epub 2019 Apr 5.

PMID:
30948820
4.

tiRNAs as a novel biomarker for cell damage assessment in in vitro ischemia-reperfusion model in rat neuronal PC12 cells.

Elkordy A, Rashad S, Shehabeldeen H, Mishima E, Niizuma K, Abe T, Tominaga T.

Brain Res. 2019 Jul 1;1714:8-17. doi: 10.1016/j.brainres.2019.02.019. Epub 2019 Feb 16.

PMID:
30779912
5.

Immuno-Northern Blotting: Detection of Modified RNA Using Gel Separation and Antibodies to Modified Nucleosides.

Mishima E, Abe T.

Methods Mol Biol. 2019;1870:179-187. doi: 10.1007/978-1-4939-8808-2_13.

PMID:
30539555
6.

Low frequency of cervicocranial artery involvement in Japanese with renal artery fibromuscular dysplasia compared with that of Caucasians.

Mishima E, Umezawa S, Suzuki T, Fujimura M, Abe M, Hashimoto J, Abe T, Ito S.

Clin Exp Nephrol. 2018 Dec;22(6):1294-1299. doi: 10.1007/s10157-018-1575-1. Epub 2018 Apr 20.

PMID:
29679353
7.

Renovascular hypertension associated with JAK2 V617F positive myeloproliferative neoplasms treated with angioplasty: 2 cases and literature review.

Mishima E, Suzuki T, Takeuchi Y, Seiji K, Fukuhara N, Takase K, Harigae H, Abe T, Ito S.

J Clin Hypertens (Greenwich). 2018 Apr;20(4):798-804. doi: 10.1111/jch.13257. Epub 2018 Apr 14. Review.

8.

Stress-induced tRNA cleavage and tiRNA generation in rat neuronal PC12 cells.

Elkordy A, Mishima E, Niizuma K, Akiyama Y, Fujimura M, Tominaga T, Abe T.

J Neurochem. 2018 Sep;146(5):560-569. doi: 10.1111/jnc.14321. Epub 2018 Apr 22.

9.

Impact of the Oral Adsorbent AST-120 on Organ-Specific Accumulation of Uremic Toxins: LC-MS/MS and MS Imaging Techniques.

Sato E, Saigusa D, Mishima E, Uchida T, Miura D, Morikawa-Ichinose T, Kisu K, Sekimoto A, Saito R, Oe Y, Matsumoto Y, Tomioka Y, Mori T, Takahashi N, Sato H, Abe T, Niwa T, Ito S.

Toxins (Basel). 2017 Dec 28;10(1). pii: E19. doi: 10.3390/toxins10010019.

10.

Focal Segmental Glomerulosclerosis Associated with Chronic Progressive External Ophthalmoplegia and Mitochondrial DNA A3243G Mutation.

Narumi K, Mishima E, Akiyama Y, Matsuhashi T, Nakamichi T, Kisu K, Nishiyama S, Ikenouchi H, Kikuchi A, Izumi R, Miyazaki M, Abe T, Sato H, Ito S.

Nephron. 2018;138(3):243-248. doi: 10.1159/000485109. Epub 2017 Nov 30.

PMID:
29190634
11.

Canagliflozin reduces plasma uremic toxins and alters the intestinal microbiota composition in a chronic kidney disease mouse model.

Mishima E, Fukuda S, Kanemitsu Y, Saigusa D, Mukawa C, Asaji K, Matsumoto Y, Tsukamoto H, Tachikawa T, Tsukimi T, Fukuda NN, Ho HJ, Kikuchi K, Suzuki C, Nanto F, Suzuki T, Ito S, Soga T, Tomioka Y, Abe T.

Am J Physiol Renal Physiol. 2018 Oct 1;315(4):F824-F833. doi: 10.1152/ajprenal.00314.2017. Epub 2017 Nov 22.

12.

Inherited, not acquired, Gitelman syndrome in a patient with Sjögren's syndrome: importance of genetic testing to distinguish the two forms.

Mishima E, Mori T, Sohara E, Uchida S, Abe T, Ito S.

CEN Case Rep. 2017 Nov;6(2):180-184. doi: 10.1007/s13730-017-0271-4. Epub 2017 Aug 17.

13.

Acute Kidney Injury from Excessive Potentiation of Calcium-channel Blocker via Synergistic CYP3A4 Inhibition by Clarithromycin Plus Voriconazole.

Mishima E, Maruyama K, Nakazawa T, Abe T, Ito S.

Intern Med. 2017;56(13):1687-1690. doi: 10.2169/internalmedicine.56.8313. Epub 2017 Jul 1.

14.

Mitochonic Acid 5 (MA-5) Facilitates ATP Synthase Oligomerization and Cell Survival in Various Mitochondrial Diseases.

Matsuhashi T, Sato T, Kanno SI, Suzuki T, Matsuo A, Oba Y, Kikusato M, Ogasawara E, Kudo T, Suzuki K, Ohara O, Shimbo H, Nanto F, Yamaguchi H, Saigusa D, Mukaiyama Y, Watabe A, Kikuchi K, Shima H, Mishima E, Akiyama Y, Oikawa Y, Hsin-Jung HO, Akiyama Y, Suzuki C, Uematsu M, Ogata M, Kumagai N, Toyomizu M, Hozawa A, Mano N, Owada Y, Aiba S, Yanagisawa T, Tomioka Y, Kure S, Ito S, Nakada K, Hayashi KI, Osaka H, Abe T.

EBioMedicine. 2017 Jun;20:27-38. doi: 10.1016/j.ebiom.2017.05.016. Epub 2017 May 13.

15.

Selective embolization therapy for intrarenal artery stenosis causing renovascular hypertension: Efficacy and follow-up renal imaging.

Mishima E, Suzuki T, Seiji K, Akiyama Y, Ota H, Hashimoto J, Takase K, Abe T, Ito S.

J Clin Hypertens (Greenwich). 2017 Oct;19(10):1028-1031. doi: 10.1111/jch.13040. Epub 2017 May 30.

16.

Potential Drug Interactions Mediated by Renal Organic Anion Transporter OATP4C1.

Sato T, Mishima E, Mano N, Abe T, Yamaguchi H.

J Pharmacol Exp Ther. 2017 Aug;362(2):271-277. doi: 10.1124/jpet.117.241703. Epub 2017 May 26.

PMID:
28550055
17.

A novel indole compound MA-35 attenuates renal fibrosis by inhibiting both TNF-α and TGF-β1 pathways.

Shima H, Sasaki K, Suzuki T, Mukawa C, Obara T, Oba Y, Matsuo A, Kobayashi T, Mishima E, Watanabe S, Akiyama Y, Kikuchi K, Matsuhashi T, Oikawa Y, Nanto F, Akiyama Y, Ho HJ, Suzuki C, Saigusa D, Masamune A, Tomioka Y, Masaki T, Ito S, Hayashi KI, Abe T.

Sci Rep. 2017 May 15;7(1):1884. doi: 10.1038/s41598-017-01702-7.

18.

Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach.

Mishima E, Fukuda S, Mukawa C, Yuri A, Kanemitsu Y, Matsumoto Y, Akiyama Y, Fukuda NN, Tsukamoto H, Asaji K, Shima H, Kikuchi K, Suzuki C, Suzuki T, Tomioka Y, Soga T, Ito S, Abe T.

Kidney Int. 2017 Sep;92(3):634-645. doi: 10.1016/j.kint.2017.02.011. Epub 2017 Apr 8.

19.

'Lead pipe'-like stiff aorta with grossly widened pulse pressure in burned-out Takayasu arteritis.

Mishima E, Suzuki T, Hashimoto J, Abe T, Ito S.

Eur Heart J Cardiovasc Imaging. 2017 Jul 1;18(7):819. doi: 10.1093/ehjci/jex047. No abstract available.

PMID:
28369232
20.

[Influence of microbiota on renal disease: The two faces of Janus].

Mishima E, Abe T.

Nihon Jinzo Gakkai Shi. 2017;59(4):557-561. Japanese. No abstract available.

PMID:
30620805
21.

Metabolic alterations by indoxyl sulfate in skeletal muscle induce uremic sarcopenia in chronic kidney disease.

Sato E, Mori T, Mishima E, Suzuki A, Sugawara S, Kurasawa N, Saigusa D, Miura D, Morikawa-Ichinose T, Saito R, Oba-Yabana I, Oe Y, Kisu K, Naganuma E, Koizumi K, Mokudai T, Niwano Y, Kudo T, Suzuki C, Takahashi N, Sato H, Abe T, Niwa T, Ito S.

Sci Rep. 2016 Nov 10;6:36618. doi: 10.1038/srep36618.

22.

The topogenic function of S4 promotes membrane insertion of the voltage-sensor domain in the KvAP channel.

Mishima E, Sato Y, Nanatani K, Hoshi N, Lee JK, Schiller N, von Heijne G, Sakaguchi M, Uozumi N.

Biochem J. 2016 Dec 1;473(23):4361-4372. Epub 2016 Sep 30.

PMID:
27694387
23.

Serious Hypocalcemia After Withdrawal of Vitamin D Analog in Bedridden Nonagenarians with Previous Thyroidectomy: A Report of Two Cases.

Mishima E, Nishimiya K, Fujiwara Y, Nishizawa M, Kiyomoto H, Ito S.

J Am Geriatr Soc. 2016 Jun;64(6):1374-6. doi: 10.1111/jgs.14171. No abstract available.

PMID:
27321630
24.

Prelude to Takotsubo cardiomyopathy: subclinical progression of antecedent myocardial ischaemia prior to symptom onset.

Mishima E, Takeuchi Y, Nagasawa T, Hashimoto J.

Eur Heart J. 2016 Oct 1;37(37):2845. Epub 2016 Jun 1. No abstract available.

PMID:
27252449
25.

Dose Reduction versus Dose-interval Prolongation in Eribulin Mesilate Monotherapy in Patients with Metastatic Breast Cancer: A Retrospective Comparative Study.

Sasaki T, Oshima Y, Mishima E, Ban A, Katsuragawa K, Nagamatsu H, Yoshioka Y, Tsukiyama I, Hisada T, Itakura Y, Mizutani M.

Yakugaku Zasshi. 2016 Jul 1;136(7):1023-9. doi: 10.1248/yakushi.15-00267. Epub 2016 Mar 31. Japanese.

26.

Periodontitis-associated septic pulmonary embolism caused by Actinomyces species identified by anaerobic culture of bronchoalveolar lavage fluid: a case report.

Endo S, Mishima E, Takeuchi Y, Ohi T, Ishida M, Yanai M, Kiyomoto H, Nagasawa T, Ito S.

BMC Infect Dis. 2015 Dec 1;15:552. doi: 10.1186/s12879-015-1286-0.

27.

Mitochonic Acid 5 Binds Mitochondria and Ameliorates Renal Tubular and Cardiac Myocyte Damage.

Suzuki T, Yamaguchi H, Kikusato M, Hashizume O, Nagatoishi S, Matsuo A, Sato T, Kudo T, Matsuhashi T, Murayama K, Ohba Y, Watanabe S, Kanno S, Minaki D, Saigusa D, Shinbo H, Mori N, Yuri A, Yokoro M, Mishima E, Shima H, Akiyama Y, Takeuchi Y, Kikuchi K, Toyohara T, Suzuki C, Ichimura T, Anzai J, Kohzuki M, Mano N, Kure S, Yanagisawa T, Tomioka Y, Toyomizu M, Tsumoto K, Nakada K, Bonventre JV, Ito S, Osaka H, Hayashi K, Abe T.

J Am Soc Nephrol. 2016 Jul;27(7):1925-32. doi: 10.1681/ASN.2015060623. Epub 2015 Nov 25.

28.

Immuno-Northern Blotting: Detection of RNA Modifications by Using Antibodies against Modified Nucleosides.

Mishima E, Jinno D, Akiyama Y, Itoh K, Nankumo S, Shima H, Kikuchi K, Takeuchi Y, Elkordy A, Suzuki T, Niizuma K, Ito S, Tomioka Y, Abe T.

PLoS One. 2015 Nov 25;10(11):e0143756. doi: 10.1371/journal.pone.0143756. eCollection 2015.

29.

Detection of Segmental Renal Ischemia by Diffusion-Weighted Magnetic Resonance Imaging: Clinical Utility for Diagnosis of Renovascular Hypertension.

Mishima E, Kikuchi K, Ota H, Akiyama Y, Suzuki T, Seiji K, Hashimoto J, Takase K, Abe T, Ito S.

J Clin Hypertens (Greenwich). 2016 Apr;18(4):364-5. doi: 10.1111/jch.12675. Epub 2015 Sep 11. No abstract available.

30.

Impact of Small Renal Ischemia in Hypertension Development: Renovascular Hypertension Caused by Small Branch Artery Stenosis.

Mishima E, Hashimoto J, Akiyama Y, Shima H, Seiji K, Takase K, Abe T, Ito S.

J Clin Hypertens (Greenwich). 2016 Mar;18(3):248-9. doi: 10.1111/jch.12661. Epub 2015 Aug 21. No abstract available.

31.

Mitochonic Acid 5 (MA-5), a Derivative of the Plant Hormone Indole-3-Acetic Acid, Improves Survival of Fibroblasts from Patients with Mitochondrial Diseases.

Suzuki T, Yamaguchi H, Kikusato M, Matsuhashi T, Matsuo A, Sato T, Oba Y, Watanabe S, Minaki D, Saigusa D, Shimbo H, Mori N, Mishima E, Shima H, Akiyama Y, Takeuchi Y, Yuri A, Kikuchi K, Toyohara T, Suzuki C, Kohzuki M, Anzai J, Mano N, Kure S, Yanagisawa T, Tomioka Y, Toyomizu M, Ito S, Osaka H, Hayashi K, Abe T.

Tohoku J Exp Med. 2015 Jul;236(3):225-32. doi: 10.1620/tjem.236.225.

32.

Posterior reversible encephalopathy syndrome treated with renin-angiotensin system blockade.

Mishima E, Hashimoto J, Akiyama Y, Seiji K, Takase K, Abe T, Ito S.

J Neurol Sci. 2015 Aug 15;355(1-2):219-21. doi: 10.1016/j.jns.2015.06.007. Epub 2015 Jun 6. No abstract available.

PMID:
26073482
33.

Alteration of the Intestinal Environment by Lubiprostone Is Associated with Amelioration of Adenine-Induced CKD.

Mishima E, Fukuda S, Shima H, Hirayama A, Akiyama Y, Takeuchi Y, Fukuda NN, Suzuki T, Suzuki C, Yuri A, Kikuchi K, Tomioka Y, Ito S, Soga T, Abe T.

J Am Soc Nephrol. 2015 Aug;26(8):1787-94. doi: 10.1681/ASN.2014060530. Epub 2014 Dec 18.

34.
35.

Exonic mutations in the SLC12A3 gene cause exon skipping and premature termination in Gitelman syndrome.

Takeuchi Y, Mishima E, Shima H, Akiyama Y, Suzuki C, Suzuki T, Kobayashi T, Suzuki Y, Nakayama T, Takeshima Y, Vazquez N, Ito S, Gamba G, Abe T.

J Am Soc Nephrol. 2015 Feb;26(2):271-9. doi: 10.1681/ASN.2013091013. Epub 2014 Jul 24.

36.

Conformational change in transfer RNA is an early indicator of acute cellular damage.

Mishima E, Inoue C, Saigusa D, Inoue R, Ito K, Suzuki Y, Jinno D, Tsukui Y, Akamatsu Y, Araki M, Araki K, Shimizu R, Shinke H, Suzuki T, Takeuchi Y, Shima H, Akiyama Y, Toyohara T, Suzuki C, Saiki Y, Tominaga T, Miyagi S, Kawagisihi N, Soga T, Ohkubo T, Yamamura K, Imai Y, Masuda S, Sabbisetti V, Ichimura T, Mount DB, Bonventre JV, Ito S, Tomioka Y, Itoh K, Abe T.

J Am Soc Nephrol. 2014 Oct;25(10):2316-26. doi: 10.1681/ASN.2013091001. Epub 2014 May 15.

37.

Indoxyl sulfate down-regulates SLCO4C1 transporter through up-regulation of GATA3.

Akiyama Y, Kikuchi K, Saigusa D, Suzuki T, Takeuchi Y, Mishima E, Yamamoto Y, Ishida A, Sugawara D, Jinno D, Shima H, Toyohara T, Suzuki C, Souma T, Moriguchi T, Tomioka Y, Ito S, Abe T.

PLoS One. 2013 Jul 9;8(7):e66518. doi: 10.1371/journal.pone.0066518. Print 2013.

38.

Mutation of the Mg2+ transporter SLC41A1 results in a nephronophthisis-like phenotype.

Hurd TW, Otto EA, Mishima E, Gee HY, Inoue H, Inazu M, Yamada H, Halbritter J, Seki G, Konishi M, Zhou W, Yamane T, Murakami S, Caridi G, Ghiggeri G, Abe T, Hildebrandt F.

J Am Soc Nephrol. 2013 May;24(6):967-77. doi: 10.1681/ASN.2012101034. Epub 2013 May 9.

39.

A metabolomic approach to clarifying the effect of AST-120 on 5/6 nephrectomized rats by capillary electrophoresis with mass spectrometry (CE-MS).

Akiyama Y, Takeuchi Y, Kikuchi K, Mishima E, Yamamoto Y, Suzuki C, Toyohara T, Suzuki T, Hozawa A, Ito S, Soga T, Abe T.

Toxins (Basel). 2012 Nov 14;4(11):1309-22. doi: 10.3390/toxins4111309.

40.

Metabolomic profiling of the autosomal dominant polycystic kidney disease rat model.

Toyohara T, Suzuki T, Akiyama Y, Yoshihara D, Takeuchi Y, Mishima E, Kikuchi K, Suzuki C, Tanemoto M, Ito S, Nagao S, Soga T, Abe T.

Clin Exp Nephrol. 2011 Oct;15(5):676-687. doi: 10.1007/s10157-011-0467-4. Epub 2011 Jun 22.

PMID:
21695416
41.

Transcriptional regulation of organic anion transporting polypeptide SLCO4C1 as a new therapeutic modality to prevent chronic kidney disease.

Suzuki T, Toyohara T, Akiyama Y, Takeuchi Y, Mishima E, Suzuki C, Ito S, Soga T, Abe T.

J Pharm Sci. 2011 Sep;100(9):3696-707. doi: 10.1002/jps.22641. Epub 2011 Jun 7. Review.

PMID:
21656517
42.

Tannerella forsythia invasion in oral epithelial cells requires phosphoinositide 3-kinase activation and clathrin-mediated endocytosis.

Mishima E, Sharma A.

Microbiology. 2011 Aug;157(Pt 8):2382-91. doi: 10.1099/mic.0.048975-0. Epub 2011 May 26.

43.

Controlled alternating copolymerization of (meth)acrylates and vinyl ethers by using organoheteroatom-mediated living radical polymerization.

Mishima E, Yamago S.

Macromol Rapid Commun. 2011 Jun 16;32(12):893-8. doi: 10.1002/marc.201100089. Epub 2011 Mar 29.

PMID:
21448909
44.

Precision synthesis of hybrid block copolymers by organotellurium-mediated successive living radical and cationic polymerizations.

Mishima E, Yamada T, Watanabe H, Yamago S.

Chem Asian J. 2011 Feb 1;6(2):445-51. doi: 10.1002/asia.201000402. Epub 2010 Nov 15.

PMID:
21254423
45.

Role of Tannerella forsythia NanH sialidase in epithelial cell attachment.

Honma K, Mishima E, Sharma A.

Infect Immun. 2011 Jan;79(1):393-401. doi: 10.1128/IAI.00629-10. Epub 2010 Nov 15.

46.

Stage of chronic kidney disease is an outcome-predicting factor of angioplasty for atheromatous renal artery stenosis.

Tanemoto M, Takeuchi Y, Mishima E, Suzuki T, Abe T, Ito S.

Hypertens Res. 2010 Nov;33(11):1206-10. doi: 10.1038/hr.2010.152. Epub 2010 Aug 12.

PMID:
20703231
47.

Metabolomic profiling of uremic solutes in CKD patients.

Toyohara T, Akiyama Y, Suzuki T, Takeuchi Y, Mishima E, Tanemoto M, Momose A, Toki N, Sato H, Nakayama M, Hozawa A, Tsuji I, Ito S, Soga T, Abe T.

Hypertens Res. 2010 Sep;33(9):944-52. doi: 10.1038/hr.2010.113. Epub 2010 Jul 8. Erratum in: Hypertens Res. 2010 Oct;33(10):1089.

PMID:
20613759
48.

The HMG-CoA reductase inhibitor pravastatin stimulates insulin secretion through organic anion transporter polypeptides.

Abe M, Toyohara T, Ishii A, Suzuki T, Noguchi N, Akiyama Y, Shiwaku HO, Nakagomi-Hagihara R, Zheng G, Shibata E, Souma T, Shindo T, Shima H, Takeuchi Y, Mishima E, Tanemoto M, Terasaki T, Onogawa T, Unno M, Ito S, Takasawa S, Abe T.

Drug Metab Pharmacokinet. 2010;25(3):274-82.

49.

Urinary stones resembling uric acid stones.

Tanemoto M, Takeuchi Y, Mishima E, Suzuki T, Abe T, Ito S.

NDT Plus. 2010 Jun;3(3):318-319. doi: 10.1093/ndtplus/sfq008. Epub 2010 Feb 28. No abstract available.

50.

Possible cause of recurrent renal artery stenosis.

Tanemoto M, Takeuchi Y, Mishima E, Abe T, Ito S.

Kidney Int. 2009 Dec;76(11):1209; author reply 1209. doi: 10.1038/ki.2009.364. No abstract available.

Supplemental Content

Loading ...
Support Center